DocDollars

Sebela Pharmaceuticals Inc.

GA · United States · Reporting entity ID 100000066371

Total reported 2019–2025
$12.2M
#438 of 2,960 reporting companies — 0% of all reported industry payments
$553K in general payments across 4,606 records, plus $11.7M in research funding across 1,612 records.

How it breaks down

General payments $553,081
Research funding $11,650,275

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Sebela Pharmaceuticals Inc. reported $12.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #438 of 2,960 reporting companies. 95% of that was research funding and 5% general payments such as consulting, speaking, food and travel. 4,606 general payment records and 1,612 research records were filed.

Common questions about Sebela Pharmaceuticals Inc.

How much has Sebela Pharmaceuticals Inc. paid US doctors?

Sebela Pharmaceuticals Inc. reported $12,203,356 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $553,081 in general payments, $11,650,275 in research funding.

How does Sebela Pharmaceuticals Inc. rank among drug and device companies?

It ranks #438 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Sebela Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.